Biotangents
Biotangents is a Scottish biotech company founded in 2015, specializing in developing innovative molecular diagnostics for the animal health sector. Their mission is to improve animal welfare, productivity, sustainability, and food security through advanced diagnostic solutions. They focus on rapid, accurate, and cost-effective tests for infectious diseases in livestock, with applications extending to human healthcare and environmental monitoring. The company is recognized for its proprietary technology, Moduleic Sensing™, and has received multiple awards and funding to support its growth and innovation.
Industries
Nr. of Employees
small (1-50)
Biotangents
14/15 Doherty Innovation Centre, Pentlands Science Park, Bush Loan, Penicuik, Midlothian EH26 0PZ, United Kingdom
Products
Laboratory molecular assay for Bovine Viral Diarrhoea (BVDV) detection
A laboratory-format nucleic-acid assay for detection of BVDV (types 1 & 2) using isothermal amplification and lyophilised reagents; reported time-to-result ~43 minutes with stated sensitivity ~99.4% and specificity ~100%.
Laboratory molecular assay for rapid identification of bovine mastitis pathogens
A laboratory-format molecular assay for rapid identification of key mastitis pathogens from milk using isothermal amplification and lyophilised bead reagents; reported time-to-result ≈70 minutes with stated sensitivity ~93% and specificity ~95% for five target pathogens.
Laboratory molecular assay for Bovine Viral Diarrhoea (BVDV) detection
A laboratory-format nucleic-acid assay for detection of BVDV (types 1 & 2) using isothermal amplification and lyophilised reagents; reported time-to-result ~43 minutes with stated sensitivity ~99.4% and specificity ~100%.
Laboratory molecular assay for rapid identification of bovine mastitis pathogens
A laboratory-format molecular assay for rapid identification of key mastitis pathogens from milk using isothermal amplification and lyophilised bead reagents; reported time-to-result ≈70 minutes with stated sensitivity ~93% and specificity ~95% for five target pathogens.
Services
Design and development of nucleic-acid-based diagnostic assays including target selection, probe design and optimization using machine-learning bioinformatics workflows.
Design and execution of independent validation studies and on-farm trials to generate performance data for pen-side and laboratory assays.
Services to transition assays from R&D prototypes to manufacturing-ready formats, including reagent formulation, process prototyping and transfer planning.
Design and development of nucleic-acid-based diagnostic assays including target selection, probe design and optimization using machine-learning bioinformatics workflows.
Design and execution of independent validation studies and on-farm trials to generate performance data for pen-side and laboratory assays.
Services to transition assays from R&D prototypes to manufacturing-ready formats, including reagent formulation, process prototyping and transfer planning.
Expertise Areas
- Point-of-care molecular diagnostics
- Veterinary and livestock infectious disease diagnostics
- Isothermal nucleic acid assay development
- Machine-learning-driven assay design and bioinformatics
Key Technologies
- Isothermal amplification (LAMP)
- Lyophilised bead reagent formulations
- Machine-learning bioinformatics
- Modular detection-amplification-reporting architecture
News & Updates
Biotangents announced a new investment round of £2.3m led by Eos Advisory, supporting the development of their rapid on-farm diagnostic device for dairy cows.
The company secured new funding and appointed new senior management, including a new investor director from Kelvin Capital.
The company was recognized for its industry-changing mastitis diagnostic device, which can differentiate pathogens within 3 hours.
The company joined the trade association supporting the UK animal health industry.
The award recognized the company's innovative approach to infectious disease diagnostics in veterinary medicine.
Lina Gasiūnaitė was a finalist in the entrepreneurship category, recognized for her pioneering work at Biotangents.
Biotangents announced a new investment round of £2.3m led by Eos Advisory, supporting the development of their rapid on-farm diagnostic device for dairy cows.
The company secured new funding and appointed new senior management, including a new investor director from Kelvin Capital.
The company was recognized for its industry-changing mastitis diagnostic device, which can differentiate pathogens within 3 hours.
The company joined the trade association supporting the UK animal health industry.
The award recognized the company's innovative approach to infectious disease diagnostics in veterinary medicine.
Lina Gasiūnaitė was a finalist in the entrepreneurship category, recognized for her pioneering work at Biotangents.